In collaboration with the Heart Institute (InCOR) at the University of São Paulo (USP), the International Federation of Medical and Biological Engineering-Health Technology Assessment (IFMBE-HTA) Division held its inaugural International Workshop on Medical Device Assessment between December 9 to 11, 2019 in São Paulo, Brazil. A total of 126 participants were in attendance, including 55 in person. In addition, 71 remote participants were from other Latin American countries, such as Colombia and Mexico.

 On Day 1 and 2, 14 presentations that addressed a range of themes were given. They are follows: HTA Networks; Medical Device Initiatives in the Americas; Medical Devices Evaluation Framework in Brazil, Europe, and Canada; Specific HTA Guidelines on Medical Devices; Post-Market Surveillance; Economic Evaluation; Nomenclatures; Medical Device HTAs in the Primary Care; and Reports on Medical Device HTAs. Presentations were given by local institution representatives, such as Evelinda Trindade (InCOR); Fotini Toscas (Ministry of Health); Saide Calil (UNICAMP); Murilo Contó (IFMBE, Brazil); José Alberto (UNIFEI) and Flavio Garcia (UFSC-IEB); as well as international speakers: Alexandre Lemgruber (PAHO-WHO); Julie Polisena (IFMBE, Canada) and Nicolas Pallikarakis (IFMBE, Greece).

 On the third day, a guided tour was held at the Radiology Institute of Hospital das Clínicas of USP. This tour enabled participants to obtain a more intimate view of the complex health technologies and procedures involved in radiotherapy treatments for cancer.

 According to feedback from participants, our first IFMBE-HTA Division Workshop on Medical Device Assessment held in Brazil was a unique opportunity to share information and raise awareness that, for numerous domains  beyond clinical and cost-effectiveness, a closer examination is necessary for medical devices. Furthermore, round table discussions served as a forum to provide important guidance on the opportunities to develop methodologies and introduce new policies to enhance the assessment of and integrate processes for medical devices across health care systems. 


Murilo Contó, BR HTAD Elected Member Specialist in Health Technology Assessment (HTA) and Health Technology Management (HTM) with more than 20 years working with medical devices, including activities in the industry, hospitals, federal government and international organization.

Julie POLISENA, Canada HTAD Coopted Member Julie Polisena is a Senior Policy Analyst in the Marketed Health Products Directorate at Health Canada. She has a Master of Science in Health Services Research from the University of Toronto and earned her doctorate in Epidemiology at the University of Ottawa. Julie also completed a PhD Fellowship in HTA at the Society for Medical Decision Making. Prior to joining Health Canada, she was a Clinical Research Manager at the Canadian Agency for Drugs and Technologies in Health. Julie was initially exposed to health technology assessment as a research assistant at Agostino Gemelli University Polyclinic in Rome, Italy. Furthermore, she co-founded the Cochrane Rapid Review Methods Group and the International Collaborative for Medical Device Assessments, and has co-authored over 30 publications in peer-reviewed medical journals.

Share This